Literature DB >> 27561427

Detection of Circulating Auto-Antibodies Against Ribosylated-LDL in Diabetes Patients.

Firoz Akhter1, M Salman Khan1, Mohammad Faisal2, Abdulrahman A Alatar2, Saheem Ahmad1.   

Abstract

BACKGROUND: This study analyzes effect of glycation on ApoB-100 residues by D-ribose as D-ribosylated-glycated LDL might be responsible for the cause of diabetes mellitus because of its far higher antigenic ability. The binding characteristics of circulating auto-antibodies in type 1 and type 2 diabetes patients against native and modified LDL were assessed.
METHODS: T1 Diabetes (n = 43), T2 diabetes patients (n = 100) were examined by direct binding ELISA as well as inhibition ELISA, were compared with healthy age-matched controls (n = 50).
RESULTS: High degree of specific binding was observed by 74.42% of T1 diabetes and 45.0% of T2 diabetes patient's sera toward glycated LDL, in comparison to its native analog. Competitive inhibition ELISA reiterates the direct binding results. Furthermore, ketoamine content, Hydroxymethylfurfural (HMF) content and carbonyl content were also estimated in patient's sera healthy subjects. The increase in total serum protein carbonyl levels in the diabetes patients was largely due to an increase in oxidative stress. The increase in ketoamine as well as HMF content inpatients sera than healthy subjects is an agreement of induced glycation reaction in patients than healthy subjects.
CONCLUSION: D-ribosylated-LDL has resulted in structural perturbation causing generation of neo-antigenic epitopes that are better antigens for antibodies in T1 and T2 diabetes patients.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  HMF content; auto-antibodies; carbonyl content; ketoamine; type 1 diabetes; type 2 diabetes, ELISA

Mesh:

Substances:

Year:  2016        PMID: 27561427      PMCID: PMC6817275          DOI: 10.1002/jcla.22039

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  32 in total

Review 1.  D-ribose in glycation and protein aggregation.

Authors:  Yan Wei; Chan Shuai Han; Jun Zhou; Ying Liu; Lan Chen; Rong Qiao He
Journal:  Biochim Biophys Acta       Date:  2012-01-17

2.  Physicochemical analysis of poly-L-lysine: An insight into the changes induced in lysine residues of proteins on modification with glucose.

Authors:  Nadeem Ahmad Ansari; Rashid Ali
Journal:  IUBMB Life       Date:  2011-01       Impact factor: 3.885

3.  Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation. Some fundamental differences in proposed mechanisms of glucose oxidation and oxidant production.

Authors:  J V Hunt; M A Bottoms; M J Mitchinson
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

Review 4.  Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging.

Authors:  H Vlassara; R Bucala; L Striker
Journal:  Lab Invest       Date:  1994-02       Impact factor: 5.662

5.  Acquired immunogenicity of calf thymus DNA and LDL modified by D-ribose: a comparative study.

Authors:  Firoz Akhter; M Salman Khan; Saheem Ahmad
Journal:  Int J Biol Macromol       Date:  2014-10-26       Impact factor: 6.953

6.  Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts.

Authors:  L Park; K G Raman; K J Lee; Y Lu; L J Ferran; W S Chow; D Stern; A M Schmidt
Journal:  Nat Med       Date:  1998-09       Impact factor: 53.440

7.  The uptake of LDL-IC by human macrophages: predominant involvement of the Fc gamma RI receptor.

Authors:  M F Lopes-Virella; N Binzafar; S Rackley; A Takei; M La Via; G Virella
Journal:  Atherosclerosis       Date:  1997-12       Impact factor: 5.162

Review 8.  Role of immune system in type 1 diabetes mellitus pathogenesis.

Authors:  Leszek Szablewski
Journal:  Int Immunopharmacol       Date:  2014-06-30       Impact factor: 4.932

9.  Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency.

Authors:  R Bucala; Z Makita; G Vega; S Grundy; T Koschinsky; A Cerami; H Vlassara
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

10.  Reaction of monosaccharides with proteins: possible evolutionary significance.

Authors:  H F Bunn; P J Higgins
Journal:  Science       Date:  1981-07-10       Impact factor: 47.728

View more
  7 in total

1.  High Dietary Advanced Glycation End Products Impair Mitochondrial and Cognitive Function.

Authors:  Firoz Akhter; Doris Chen; Asma Akhter; Alexander A Sosunov; Allen Chen; Guy M McKhann; Shi Fang Yan; Shirley ShiDu Yan
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

2.  Oxidative Modification of LDL by Various Physicochemical Techniques: Its Probable Role in Diabetes Coupled with CVDs.

Authors:  Sultan Alouffi; Mohammad Faisal; Abdulrahman A Alatar; Saheem Ahmad
Journal:  Biomed Res Int       Date:  2018-11-18       Impact factor: 3.411

Review 3.  On the irrationality of rational design of an HIV vaccine in light of protein intrinsic disorder.

Authors:  Vladimir N Uversky
Journal:  Arch Virol       Date:  2021-02-19       Impact factor: 2.574

4.  The Neoepitopes on Methylglyoxal- (MG-) Glycated Fibrinogen Generate Autoimmune Response: Its Role in Diabetes, Atherosclerosis, and Diabetic Atherosclerosis Subjects.

Authors:  Shahnawaz Rehman; Jiantao Song; Mohammad Faisal; Abdulrahman A Alatar; Firoz Akhter; Saheem Ahmad; Bo Hu
Journal:  Oxid Med Cell Longev       Date:  2021-12-21       Impact factor: 6.543

5.  Proteins in human body fluids contain in vivo antigen analog of the melibiose-derived glycation product: MAGE.

Authors:  Kinga Gostomska-Pampuch; Andrzej Gamian; Karol Rawicz-Pruszyński; Katarzyna Gęca; Joanna Tkaczuk-Włach; Ilona Jonik; Kinga Ożga; Magdalena Staniszewska
Journal:  Sci Rep       Date:  2022-05-07       Impact factor: 4.996

6.  HIF-1α Ameliorates Diabetic Neuropathic Pain via Parkin-Mediated Mitophagy in a Mouse Model.

Authors:  Jian He; Zaisheng Qin; Xin Chen; Wanyou He; Donglin Li; Lei Zhang; Yue Le; Qingming Xiong; Bin Zhang; Hanbing Wang
Journal:  Biomed Res Int       Date:  2022-08-16       Impact factor: 3.246

7.  Circulating antibodies against age-modified proteins in patients with coronary atherosclerosis.

Authors:  Edina Korça; Veronika Piskovatska; Jochen Börgermann; Alexander Navarrete Santos; Andreas Simm
Journal:  Sci Rep       Date:  2020-10-13       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.